These results are in line with a recent study by Kuhn et al. showing that the chromatin binding of MLL1 is critical for NPM1-mutated leukemias and Menin-Mll1 interaction controls the expression of HOX, MEIS1, and FLT3 genes in NPM1-mutated AML17. The gene discussed is KMT2A; the disease is leukemia.